共查询到20条相似文献,搜索用时 15 毫秒
1.
Characterization of a MEN1 ortholog from Drosophila melanogaster 总被引:2,自引:0,他引:2
Guru SC Prasad NB Shin EJ Hemavathy K Lu J Ip YT Agarwal SK Marx SJ Spiegel AM Collins FS Oliver B Chandrasekharappa SC 《Gene》2001,263(1-2):31-38
2.
3.
Characterization of mutations in patients with multiple endocrine neoplasia type 1. 总被引:9,自引:0,他引:9
下载免费PDF全文
![点击此处可从《American journal of human genetics》网站下载免费的PDF全文](/ch/ext_images/free.gif)
J H Bassett S A Forbes A A Pannett S E Lloyd P T Christie C Wooding B Harding G M Besser C R Edwards J P Monson J Sampson J A Wass M H Wheeler R V Thakker 《American journal of human genetics》1998,62(2):232-244
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder characterized by tumors of the parathyroids, pancreatic islets, and anterior pituitary. The MEN1 gene, on chromosome 11q13, has recently been cloned, and mutations have been identified. We have characterized such MEN1 mutations, assessed the reliability of SSCP analysis for the detection of these mutations, and estimated the age-related penetrance for MEN1. Sixty-three unrelated MEN1 kindreds (195 affected and 396 unaffected members) were investigated for mutations in the 2,790-bp coding region and splice sites, by SSCP and DNA sequence analysis. We identified 47 mutations (12 nonsense mutations, 21 deletions, 7 insertions, 1 donor splice-site mutation, and 6 missense mutations), that were scattered throughout the coding region, together with six polymorphisms that had heterozygosity frequencies of 2%-44%. More than 10% of the mutations arose de novo, and four mutation hot spots accounted for >25% of the mutations. SSCP was found to be a sensitive and specific mutational screening method that detected >85% of the mutations. Two hundred and one MEN1 mutant-gene carriers (155 affected and 46 unaffected) were identified, and these helped to define the age-related penetrance of MEN1 as 7%, 52%, 87%, 98%, 99%, and 100% at 10, 20, 30, 40, 50, and 60 years of age, respectively. These results provide the basis for a molecular-genetic screening approach that will supplement the clinical evaluation and genetic counseling of members of MEN1 families. 相似文献
4.
5.
Mireille J. de Wit Rudy M. Landsvater Richard J. Sinke A. Geurts van Kessel Cornelis J. M. Lips J. W. M. Höppener Mireille J. de Wit 《Human genetics》1996,99(1):133-137
Multiple endocrine neoplasia type 1 (MEN 1) is inherited as an autosomal dominant disorder, characterized by hyperplasia
and neoplasia in several endocrine organs. The MEN 1 gene, which is most probably a tumor suppressor gene, has been localized
to a 900-kb region on chromosome 11q13. The human phosphatidylinositol-specific phospholipase C β3 (PLC β3) gene, which is
located within this region, was considered to be a good candidate for the MEN 1 gene. In this study, the structure and expression
of the PLC β3 gene in MEN 1 patients were investigated in more detail, to determine its potential role in MEN 1 tumorigenesis.
Southern blot analysis, using blood and tumor DNA from affected persons from seven different MEN 1 families, did not reveal
structural abnormalities in the PLC β3 gene. To detect possible point mutations, or other small structural aberrations, direct
sequencing of PLC β3 cDNAs from two affected persons from two different MEN 1 families was performed, but no MEN 1-specific
abnormalities were revealed. Several common nucleotide sequence polymorphisms were detected in these cDNAs, proving that both
alleles of the PLC β3 gene were expressed and analyzed. In conclusion, these results exclude the PLC β3 gene as a candidate
gene for MEN 1.
Received: 20 March 1996 相似文献
6.
7.
8.
Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. 总被引:3,自引:0,他引:3
下载免费PDF全文
![点击此处可从《American journal of human genetics》网站下载免费的PDF全文](/ch/ext_images/free.gif)
S Giraud C X Zhang O Serova-Sinilnikova V Wautot J Salandre N Buisson C Waterlot C Bauters N Porchet J P Aubert P Emy G Cadiot B Delemer O Chabre P Niccoli F Leprat F Duron B Emperauger P Cougard P Goudet E Sarfati J P Riou S Guichard M Rodier A Meyrier P Caron M C Vantyghem M Assayag J L Peix M Pugeat V Rohmer M Vallotton G Lenoir P Gaudray C Proye B Conte-Devolx P Chanson Y Y Shugart D Goldgar A Murat A Calender 《American journal of human genetics》1998,63(2):455-467
Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant syndrome predisposing to tumors of the parathyroid, endocrine pancreas, anterior pituitary, adrenal glands, and diffuse neuroendocrine tissues. The MEN1 gene has been assigned, by linkage analysis and loss of heterozygosity, to chromosome 11q13 and recently has been identified by positional cloning. In this study, a total of 84 families and/or isolated patients with either MEN1 or MEN1-related inherited endocrine tumors were screened for MEN1 germ-line mutations, by heteroduplex and sequence analysis of the MEN1 gene-coding region and untranslated exon 1. Germ-line MEN1 alterations were identified in 47/54 (87%) MEN1 families, in 9/11 (82%) isolated MEN1 patients, and in only 6/19 (31.5%) atypical MEN1-related inherited cases. We characterized 52 distinct mutations in a total of 62 MEN1 germ-line alterations. Thirty-five of the 52 mutations were frameshifts and nonsense mutations predicted to encode for a truncated MEN1 protein. We identified eight missense mutations and five in-frame deletions over the entire coding sequence. Six mutations were observed more than once in familial MEN1. Haplotype analysis in families with identical mutations indicate that these occurrences reflected mainly independent mutational events. No MEN1 germ-line mutations were found in 7/54 (13%) MEN1 families, in 2/11 (18%) isolated MEN1 cases, in 13/19 (68. 5%) MEN1-related cases, and in a kindred with familial isolated hyperparathyroidism. Two hundred twenty gene carriers (167 affected and 53 unaffected) were identified. No evidence of genotype-phenotype correlation was found. Age-related penetrance was estimated to be >95% at age >30 years. Our results add to the diversity of MEN1 germ-line mutations and provide new tools in genetic screening of MEN1 and clinically related cases. 相似文献
9.
10.
11.
12.
Steven A. Narod Hagay Sobol Yusuke Nakamura Claude Calmettes Jean-Louis Baulieu Jean-Claude Bigorgne Gérard Chabrier Jean Couette Jean-Luc de Gennes Jacques Duprey Paule Gardet Pierre-Jean Guillausseau Denis Guilloteau Chantal Houdent Jean Lefebvre Elisabeth Modigliani Claude Parmentier Michel Pugeat Catherine Siame Jacques Tourniaire Jean-Claude Vandroux Jean-Michel Vinot Gilbert M. Lenoir 《Human genetics》1989,83(4):353-358
Summary The use of polymorphic DNA segments as markers for the gene for the multiple endocrine neoplasia (MEN) syndrome, type 2a, allows the identification of family members at high risk for developing medullary carcinoma of the thyroid and other tumors, especially pheochromocytoma. Several families have also been identified in which medullary thyroid carcinoma is inherited, but pheochromocytoma is not seen. We have analysed 18 families, 9 with MEN 2A and 9 with medullary carcinoma of the thyroid without pheochromocytoma, with probes specific for the pericentromeric region of chromosome 10 and conclude that the mutations for the two presentations are closely situated. Genetic heterogeneity of the susceptibility locus was not seen among this sample of 18 families. The genetic mutation for medullary carcinoma was in disequilibrium with the marker alleles of the two closely linked probes. IRBPH4 and MCK2. These data suggest that different mutant alleles of the same gene or closely linked mutations account for the variation in penetrance of pheochromocytoma in families with hereditary, medullary thyroid carcinoma. 相似文献
13.
14.
15.
Günther Weber Sean Grimmond Jacob Lagercrantz Eitan Friedman Catherine Phelan Emma Carson Nicholas Hayward Orit Jacobovitz Magnus Nordenskjöld Catharina Larsson 《Human genetics》1996,99(1):130-132
The predisposing genetic defect in multiple endocrine neoplasia type 1 has been assigned to chromosomal region 11q13. Our
previous attempts to identify the MEN1 gene have resulted in the isolation of the phospholipase Cβ3 gene from the actual region.
PLCB3 plays an important role in signal transduction and, moreover, shows loss of expression in some endocrine tumors, in accordance
with a putative tumor suppressor gene function, and thus appears to be an excellent candidate for MEN1. We have therefore
undertaken screening for constitutional mutations in individuals from MEN1 families. Several sequence alterations have been
discovered, none of them however fulfilling the criteria for a disease-related mutation. We can now exclude PLCB3 from candidacy as the MEN1 gene.
Received: 24 July 1996 / Revised: 16 August 1996 相似文献
16.
17.
Structural basis for the regulation of splicing of a yeast messenger RNA 总被引:33,自引:0,他引:33
18.
Scrambled exons 总被引:23,自引:0,他引:23
J M Nigro K R Cho E R Fearon S E Kern J M Ruppert J D Oliner K W Kinzler B Vogelstein 《Cell》1991,64(3):607-613
19.